125 related articles for article (PubMed ID: 36640671)
1. Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis.
Xu Y; Song D; Su Y; Chen J; Wu L; Lian H; Hai N; Li J; Jiang J; Zhao J; Xu J; Liu Q
Biomed Pharmacother; 2023 Mar; 159():114101. PubMed ID: 36640671
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation.
Reziwan K; Sun D; Zhang B; Zhao Z
Cell Biochem Funct; 2019 Jun; 37(4):256-265. PubMed ID: 31017694
[TBL] [Abstract][Full Text] [Related]
3. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
Kanzaki H; Shinohara F; Kajiya M; Kodama T
J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
Hyeon S; Lee H; Yang Y; Jeong W
Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
[TBL] [Abstract][Full Text] [Related]
7. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-
Wong P; Lv Z; Li J; Wei Q; Xu L; Fang B; Luo Y; He M
Oxid Med Cell Longev; 2022; 2022():5982014. PubMed ID: 36388169
[TBL] [Abstract][Full Text] [Related]
8. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.
Chen D; Ye Z; Wang C; Wang Q; Wang H; Kuek V; Wang Z; Qiu H; Yuan J; Kenny J; Yang F; He J; Liu Y; Wang G; Zhang M; Zhang G; Wang J; Chen P; Xu J
Pharmacol Res; 2020 Sep; 159():104944. PubMed ID: 32454224
[TBL] [Abstract][Full Text] [Related]
9. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
10. Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells.
Liu M; Liu S; Zhang Q; Fang Y; Yu Y; Zhu L; Liu Y; Gong W; Zhao L; Qin L; Zhang Q
J Ethnopharmacol; 2021 Jul; 275():114129. PubMed ID: 33878416
[TBL] [Abstract][Full Text] [Related]
11. Icariin ameliorates osteoporosis in ovariectomized rats by targeting Cullin 3/Nrf2/OH pathway for osteoclast inhibition.
Si Y; Li Y; Gu K; Yin H; Ma Y
Biomed Pharmacother; 2024 Apr; 173():116422. PubMed ID: 38471268
[TBL] [Abstract][Full Text] [Related]
12. VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production.
Miao J; Tu Y; Jiang J; Ren R; Wu Q; Liang H; Wang T; Lin B; Wu J; Pan Y; Wang X; Jin H
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129357. PubMed ID: 38216011
[TBL] [Abstract][Full Text] [Related]
13. Corynoline Suppresses Osteoclastogenesis and Attenuates ROS Activities by Regulating NF-κB/MAPKs and Nrf2 Signaling Pathways.
Jin C; Yu XB; Yang J; Lin Z; Ma RX; Lin BH; Zhang HJ; Dai ZH; Xue K; Xie CL; Zheng W; Feng Y; Xiao J; Yang L
J Agric Food Chem; 2024 Apr; 72(14):8149-8166. PubMed ID: 38551844
[TBL] [Abstract][Full Text] [Related]
14. Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling.
Thummuri D; Naidu VGM; Chaudhari P
J Mol Med (Berl); 2017 Oct; 95(10):1065-1076. PubMed ID: 28674855
[TBL] [Abstract][Full Text] [Related]
15. Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway.
Wei L; Chen W; Huang L; Wang H; Su Y; Liang J; Lian H; Xu J; Zhao J; Liu Q
Pharmacol Res; 2022 Oct; 184():106400. PubMed ID: 35988868
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.
Yamaguchi Y; Kanzaki H; Katsumata Y; Itohiya K; Fukaya S; Miyamoto Y; Narimiya T; Wada S; Nakamura Y
J Cell Mol Med; 2018 Feb; 22(2):1138-1147. PubMed ID: 29063666
[TBL] [Abstract][Full Text] [Related]
17. Orcinol Glucoside Improves Senile Osteoporosis through Attenuating Oxidative Stress and Autophagy of Osteoclast via Activating Nrf2/Keap1 and mTOR Signaling Pathway.
Gong W; Liu M; Zhang Q; Zhang Q; Wang Y; Zhao Q; Xiang L; Zheng C; Zhang Q; Qin L
Oxid Med Cell Longev; 2022; 2022():5410377. PubMed ID: 35585885
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 activation attenuates both orthodontic tooth movement and relapse.
Kanzaki H; Shinohara F; Itohiya-Kasuya K; Ishikawa M; Nakamura Y
J Dent Res; 2015 Jun; 94(6):787-94. PubMed ID: 25795629
[TBL] [Abstract][Full Text] [Related]
19. Probucol suppresses osteoclastogenesis via activating Nrf2 signaling and ameliorates ovariectomy-induced bone loss.
Guo J; Ren R; Guo Z; Sun K; He J; Shao J; Wang X
Int Immunopharmacol; 2023 Mar; 116():109820. PubMed ID: 36758295
[TBL] [Abstract][Full Text] [Related]
20. Urolithin B suppresses osteoclastogenesis via inhibiting RANKL-induced signalling pathways and attenuating ROS activities.
Qu Z; An H; Feng M; Huang W; Wang D; Zhang Z; Yan L
J Cell Mol Med; 2022 Aug; 26(16):4428-4439. PubMed ID: 35781786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
